Reducing antibiotic prophylaxis: impact on endocarditis incidence.

Antibiotic prophylaxis before dental procedures has been the gold standard in preventing infective endocarditis, despite the lack of supporting evidence. In 2008, the National Institute for Health and Clinical Excellence in the UK recommended the cessation of antibiotic prophylaxis before dental procedures and other invasive procedures. 

Prescription rates were drastically reduced after 2008 recommendation and, as a consequence, infective endocarditis rates increased significantly both in high and moderate risk groups.

Conclusion

Since the new guidelines on prophylaxis cessation were adopted in 2008, a significant increase in infective endocarditis was observed. Further studies are needed to reconsider the strategies currently in place. 

2_mark_dayer
Mark J Dayer
2014-11-19

Original Title: The Incidence of Infective Endocarditis in England is Increasing – An Assessment of the Impact of Cessation of Antibiotic Prophylaxis Using Population Statistics.

More articles by this author

Mitral valve repair in moderate ischemic mitral regurgitation

Article Up to 50% of acute myocardial infarctions are associated to mitral regurgitation of some degree and 10% of these cases present, at least, moderate...

INHERIT: Losartan in hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is the most common hereditary cardiac pathology (1/1500) and is associated to heart failure, angina, arrhythmia, and sudden death.  So far, no...

Atenolol vs. Losartan in children and young adults with Marfan syndrome

Article Aortic root dissection is the main cause of mortality in Marfan syndrome. Recent studies suggest that losartan could more effective to slow aortic root...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...